Related Experiment Video
Updated: Sep 27, 2026

Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury
Published on: August 16, 2019
Promising strategies to minimize secondary brain injury after head trauma
Hülya Bayir1, Robert S B Clark, Patrick M Kochanek
1Safar Center for Resuscitation Research and Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Objective:
To review novel therapeutic approaches in the treatment of severe traumatic brain injury.
Design:
Eighty-three studies were reviewed specific to the treatment of traumatic brain injury, in either experimental models or in patients.
Conclusion:
Four therapeutic strategies appear to be the most promising approaches currently in clinical trials for severe traumatic brain injury: a) the novel pharmacologic agent dexanabinol; b) hypertonic saline; c) mild hypothermia; and d) decompressive craniectomy. Each of these therapies share the common feature of targeting multiple mechanisms, suggesting this may be an important factor to the development of a successful approach to severe traumatic brain injury.
Insights
Novel treatments for severe traumatic brain injury (TBI) show promise. Four strategies, including dexanabinol, hypertonic saline, mild hypothermia, and decompressive craniectomy, target multiple mechanisms for TBI recovery.
Area of Science:
- Neuroscience
- Trauma Surgery
- Pharmacology
Background:
- Severe traumatic brain injury (TBI) presents significant management challenges.
- Current treatment paradigms for severe TBI have limitations.
- There is a critical need for innovative therapeutic strategies.
Purpose of the Study:
- To review emerging therapeutic approaches for severe traumatic brain injury (TBI).
- To identify promising treatments currently under investigation for TBI.
Main Methods:
- A comprehensive review of 83 studies was conducted.
- Studies included both experimental models and human clinical trials for TBI.
- Focus was on novel therapeutic interventions for severe TBI.
Main Results:
- Four therapeutic strategies demonstrated significant promise in clinical trials for severe TBI.
- These include the pharmacologic agent dexanabinol, hypertonic saline, mild hypothermia, and decompressive craniectomy.
- All promising therapies target multiple underlying mechanisms of TBI.
Conclusions:
- Dexanabinol, hypertonic saline, mild hypothermia, and decompressive craniectomy are leading novel treatments for severe TBI.
- The multi-target approach of these therapies is a key factor in their potential success.
- Further clinical investigation is warranted for these promising TBI treatments.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Traumatic Brain Injury l: Introduction
